Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Operating Income 2020–2025
Cytek Biosciences, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cytek Biosciences, Inc. operating income for the quarter ending March 31, 2026 was -18.5 M, a 23.29% increase year-over-year.
- Cytek Biosciences, Inc. operating income for the twelve months ending March 31, 2026 was -53.3 M, a 77.93% increase year-over-year.
- Cytek Biosciences, Inc. annual operating income for 2025 was -40.4 M, a 96.77% increase from 2024.
- Cytek Biosciences, Inc. annual operating income for 2024 was -20.5 M, a 26.30% decrease from 2023.
- Cytek Biosciences, Inc. annual operating income for 2023 was -27.8 M, a 1443.51% increase from 2022.
- Cytek Biosciences, Inc. annual operating income for 2022 was -1.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytek Biosciences, Inc. Operating Income — FAQ
Cytek Biosciences, Inc. (CTKB) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Cytek Biosciences, Inc.'s operating income?
Cytek Biosciences, Inc. (CTKB) reported operating income of -$40M for fiscal 2025.
Where can I see CTKB's operating income history?
The chart and table above show Cytek Biosciences, Inc.'s operating income by year and by quarter, including the growth rate.